Table 1.
UCD | MCD | P | |
---|---|---|---|
Age (mean, years) | 30.44 ± 8.00 | 41.56 ± 13.50 | 0.004 |
Gender | |||
Male | 8/50% | 11/34.4% | 0.2967 |
Female | 8/50% | 21/65.6% | |
Pathological type | |||
Hyaline vascular | 3/18.75% | 16/50% | |
Plasma cell | 12/75% | 12/37.5% | 0.049 |
Mixed | 1/6.25% | 4/12.5% | |
Non-symptomatic | 8/50% | 1/3.1% | <0.001 |
Fever | 0 | 16/50% | <0.001 |
Pleural effusion | 2/12.5% | 13/40.6% | 0.0475 |
Hepatomegaly and/or splenomegaly | 0 | 16/50% | <0.001 |
Anemia | 3/18.8% | 15/46.9% | 0.0578 |
Hemoglobin (g/l) | 133.13 ± 29.70 | 108.66 ± 26.60 | 0.0059 |
Platelet (×10 9 /l) | |||
>300 × 10 9 /l | 4/25% | 12/37.5% | 0.6785 |
<100 × 10 9 /l | 1/8.3% | 2/10% | |
Hypoalbuminia | 4/25% | 22/68.8% | 0.0041 |
Elevation of serum LDH ‡ | 5/30% | 5/16.1% | 0.6731 |
HIV-Ab | |||
Not done | 0 | 6/18.75% | |
Negative | 16/100% | 26/100% (n = 26) | 1 |
Chemotherapy cases | 0 | 28/87.5% | <0.001 |
Outcomes | |||
Cured | 16/100% | 0 | |
Improved | 0 | 18/56.3% | |
Stable | 0 | 7/21.9% | <0.001 |
Died | 0 | 3/9.4% | |
Lost follow-up | 0 | 4/12.5% |
‡Fifteen UCD cases and 31 MCD cases were detected with serum LDH. LDH: lactate dehydrogenase, HIV: human immunodeficiency virus.